SavedAdd your journal

Journals / Annals of Medical Research / 2018 / Cilt: 25 - Sayı: 3

The effect of the severity of nicotine dependence on psychopathology, insight and illness severity in schizophrenia

Zeynep Baran TATAR
Pages
349–354
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Those with severe nicotine dependence were also prescribed higher doses of antipsychotic.Conclusions: Our findings indicate an association between nicotine dependence, positive symptoms and severity of illness.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Compared to the general healthy population, and other psychiatric disorders the prevalence of smoking is found to be much higher among people with schizophrenia.
📊
Key Findings & Data:Four hundred and ten schizophrenia patients were administered by the Positive and Negative Symptom Scale (PANSS), Schedule for Assessment of Insight (SAI), Clinical Global Impression Severity of Illness (CGI-S) and the Turkish version of Fagerstrom Test for Nicotine Dependence (FTND).Results: The prevalence of nicotine dependence among the patients was 49.0%.
💡
Conclusion & Impact:Those with severe nicotine dependence were also prescribed higher doses of antipsychotic.Conclusions: Our findings indicate an association between nicotine dependence, positive symptoms and severity of illness.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Compared to the general healthy population, and other psychiatric disorders the prevalence of smoking is found to be much higher among people with schizophrenia. Our study aims to determine the prevalence of nicotine dependence and investigate the effects of the severity of nicotine dependence on psychopathology, illness severity and insight in a population of people with schizophrenia.Material and Methods: A cross-sectional study was carried out in a psychotic disorders outpatient clinic at Bakirkoy Training and Research Hospital. Four hundred and ten schizophrenia patients were administered by the Positive and Negative Symptom Scale (PANSS), Schedule for Assessment of Insight (SAI), Clinical Global Impression Severity of Illness (CGI-S) and the Turkish version of Fagerstrom Test for Nicotine Dependence (FTND).Results: The prevalence of nicotine dependence among the patients was 49.0%. The one-way analysis of variance revealed that subjects with severe nicotine dependence scored more in the positive subscale of PANSS and CGI-S compared with patients with mild-moderate nicotine dependence. Those with severe nicotine dependence were also prescribed higher doses of antipsychotic.Conclusions: Our findings indicate an association between nicotine dependence, positive symptoms and severity of illness. Identifying this relationship can be helpful in the management of smoking cessation treatment in patients with schizophrenia.

🔖

Cite This Article

TATAR, Z. B. (2022). The effect of the severity of nicotine dependence on psychopathology, insight and illness severity in schizophrenia. Annals of Medical Research, Cilt: 25 - Sayı: 3, 349–354. https://ajindex.com/articles/447262

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Gut-Fayand A, Dervaux A, Olié JP, Lôo H, Poirier MF, Krebs MO. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 2001;102(1): 65–72.
  2. B Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, et al. Smoking induced ventral striatum dopamine release. Am J Psychiatry 2004;161(7):1211–8. George Y. Neurobiological links between nicotine addiction and schizophrenia. J Dual Diagn 2007;3:27–42.
  3. Zhang XY, Li CB, Li M, Zheng YL, Zhang CX, Yan QZ, et al. Smoking initiation and schizophrenia: a replication study in a Chinese Han population. Schizophr Res 2010;119(1- 3):110-4.
  4. De Leon J, Gurpegui M, Diaz FJ. Epidemiology of comorbid tobacco use and schizophrenia: Thinking about risks and protective factors. Journal of Dual Diagnosis 2007;3:9-25.
  5. Chaves L, Shirakawa I. Nicotine use in patients with schizophrenia evaluated by the Fagerström Tolerance Questionnaire: a descriptive analysis from a Brazilian sample. Rev Bras Psiquiatr 2008;30(4):350-2.
  6. Yee A, Bt Nek Mohamed NN, Binti Hashim AH, Loh HS, Harbajan Singh MK, Ng CG, et al. The effect of nicotine dependence on psychopathology in patients with schizophrenia. Biomed Res Int 2015;2015:730291. Centers for Disease Control and Prevention Cigarette smoking among adults--United States, 2004. MMWR Morb Mortal Wkly Rep 2005;54(44):1121–24. LLerena A, de la Rubia A, Peñas-Lledó EM, Diaz FJ, de Leon J. Schizophrenia and tobacco smoking in a Spanish psychiatric hospital. Schizophr Res 2003;60(2-3):313-7. Küresel Yetişkin Tütün Araştırması Türkiye 2012. www. halksagligiens.hacettepe.edu.tr/KYTA_ TR.pdf. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64(6):663-7.
  7. Atkins M, Burgess A, Bottomley C. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatric Bulletin 1997;21:224-6.
  8. Uysal MA, Kadakal F, Karşıdağ Ç, Bayram NG, Uysal Ö, Yılmaz V. Fagerstrom nikotin bağımlılık testinin Türkçe versiyonun güvenirliği ve faktör analizi. Tuberk Toraks 2004;52(2):115-21. Guy W. ECDEU Assessment manual for psychopharmacology. revised US dept health, education and welfare publication (ADM), Rockville, Md:National Institude of Mental Health 1976;76-338.
  9. Arslan S, Günay Kılıç B, Karakılıç H. İçgörünün Üç Bileşenini Değerlendirme ölçeği güvenirlik ve geçerlik çalışması [Three Components of Insight Assessment Scale reliability and validity study]. Türkiye’de Psikiyatri. 2000;